Crystal form of prostaglandin analogue, and preparation method and use thereof
US9278902B2 · kind B2 · utility
12Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 10, 2013 |
| Grant date | Mar 8, 2016 |
| Priority date | — |
| Expiry date | Jan 10, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided are a crystal form B of a compound having the structure as represented by formula I, and preparation method and use thereof. The X-ray powder diffraction (XRPD) chart of the crystal form B has characteristic peaks at the following diffraction angles: 2.9±0.2°, 6.5±0.2°, 12.6±0.2°, 13.1±0.2° and 20.6±0.2°.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.